tiprankstipranks
Trending News
More News >
AstraZeneca PLC (SE:AZN)
:AZN
Sweden Market

AstraZeneca (AZN) Income Statement

Compare
2 Followers

AstraZeneca Income Statement

Last quarter (Q3 2025), AstraZeneca's total revenue was $15.19B, an increase of 8.78% from the same quarter last year. In Q3, AstraZeneca's net income was $2.53B. See AstraZeneca’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 52.94B$ 46.58B$ 44.25B$ 37.11B$ 29.27B
Gross Profit
$ 39.70B$ 34.45B$ 28.04B$ 22.60B$ 21.66B
Operating Expenses
$ 27.18B$ 24.88B$ 22.99B$ 19.79B$ 16.69B
Depreciation and Amortization
$ 4.96B$ 5.02B$ 5.24B$ 4.02B$ 3.07B
EBITDA
$ 14.86B$ 13.20B$ 8.63B$ 4.59B$ 8.04B
Operating Income
$ 12.52B$ 9.57B$ 5.05B$ 2.81B$ 4.97B
Other Income/Expenses
$ -4.01B$ -2.55B$ -2.55B$ -3.07B$ -815.71M
Pretax Income
$ 8.51B$ 7.02B$ 2.50B$ -259.92M$ 4.15B
Net Income
$ 6.89B$ 6.06B$ 3.28B$ 109.85M$ 3.39B
Per Share Metrics
Basic EPS
$ 4.44$ 3.91$ 2.12$ 0.08$ 2.58
Diluted EPS
$ 4.41$ 3.88$ 2.10$ 0.08$ 2.58
Weighted Average Shares Outstanding
1.55B 1.56B 1.55B 1.42B 1.31B
Weighted Average Shares Outstanding (Diluted)
1.56B 1.56B 1.56B 1.43B 1.31B
Currency in USD

AstraZeneca Earnings and Revenue History